This inventor holds 1 USPTO granted patent. Top assignee: King Saud University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Usama Sayed Eisa Karama: Innovator in Anti-Cancer Compounds
Introduction
Usama Sayed Eisa Karama is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Usama holds a patent for halogenated tetracyclic compounds, which are represented by a specific formula. These compounds are designed to serve as anti-cancer agents, showcasing his commitment to advancing medical science. The patent details that the compounds can exist in various forms, depending on the chemical structure, which adds versatility to their application in pharmaceuticals.
Career Highlights
Usama is affiliated with King Saud University, where he engages in research and development activities. His role at the university allows him to collaborate with other experts in the field and contribute to academic advancements. His work is characterized by a focus on innovative solutions to complex health issues.
Collaborations
Usama has worked alongside notable colleagues, including Mujeeb Abdullah Saeed Sultan and Abdulrahman Ibrahim Almansour. These collaborations enhance the research environment and foster the exchange of ideas, leading to more robust scientific outcomes.
Conclusion
Usama Sayed Eisa Karama is a dedicated inventor whose work in anti-cancer compounds exemplifies the intersection of innovation and healthcare. His contributions are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile